SCR-LIP-000537 · Claim · machine-readable JSON →
In a case series of 24 patients and a narrative review (>1,500 patients), liposuction (TLAL, VASER, WAL) reduced spontaneous pain (VAS 7.10→2.00), edema (8.50→2.10), and conservative-therapy needs, with benefits sustained up to 12 years, but stage I-II patients reduced CDT needs more than stage III (50% vs 16.7%, p=0.0019), framing it as symptom management when conservative therapy fails rather than a cure.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Outcomes of liposuction techniques for management of lipedema: a case series and narrative review (2024) ✓ verified — refining · case series · 2024 · reading confidence: high
“A lipoaspiração demonstrou ser alternativa segura e eficaz quando a terapia conservadora falha no tratamento do lipedema. Todas as técnicas utilizadas tiveram impacto positivo em desfechos clínicos e relatados pelo paciente, com benefícios mantidos ao longo do tempo.”
The article reports sustained symptom improvement and reduced need for conservative therapy after liposuction (benefits maintained up to 12 years without significant regression), suggesting modification of disease burden. However, it is fra
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000028
- 2026-11-20 — consolidated · SQ-LIP-000028: evidence moved to SCR-LIP-000734